Skyepharma Balance Sheet - Quarterly (OTCMKTS:SKYEY)

Add to My Stocks
$6.28 $0.02 (0.32%) SKYEY stock closing price Jun 24, 2016 (Closing)

A thorough fundamental analysis involves using data from Skyepharma balance sheet, apart from other financial statements, to value the business. As in our Skyepharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. A company releases its balance sheet every quarter along with its quarterly results. The Skyepharma balance sheet for 2015 Q4 shows total assets of $157.78M. The company has a asset turnover ratio of . Also see: Skyepharma revenue and Skyepharma operating cash flow for the same quarter.

View and download Skyepharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Fiscal year is Jan - Dec2015 Q4
Cash62.83M
Marketable Securities-
Receivables22.78M
Inventory14.21M
Raw Materials9.93M
Work In Progress2.44M
Finished Goods2.44M
Notes Receivable-
Other Current Assets-
Total Current Assets
99.99M
Property Plant & Equipment-
Accumulated Depreciation-
Net Property Plant & Equipment
38.07M
Investment & Advances-
Other Non-Current Assets-
Deferred Charges2.9M
Intangibles9.93M
Deposits & Other Assets6.88M
Total Assets
157.78M
Notes Payable23.74M
Accounts Payable45.86M
Current Portion Long-Term Debt4.58M
Current Portion Capital Leases-
Accrued Expenses-
Income Taxes Payable6.42M
Other Current Liabilities1.22M
Total Current Liabilities
58.1M
Mortgages-
Deferred Taxes/Income5.96M
Convertible Debt-
Long-Term Debt7.33M
Non-Current Capital Leases-
Other Long-Term Liabilities10.09M
Total Liabilities
81.49M
Minority Interest-
Preferred Stock-
Common Stock Net274.29M
Capital Surplus622.58M
Retained Earnings-779.3M
Treasury Stock-
Other Liabilities-41.28M
Shareholders Equity76.29M
Total Liabilities & Shareholders Equity157.78M
All figures in USD. M: Millions of USD, B: Billions of USD.

Apart from balance sheet items, an investor would do well to keep track of the Skyepharma stock price by looking at Skyepharma historical stock prices. One can compare PE with industry average by looking at the Skyepharma PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Skyepharma owns and has monetary significance. SKYEY assets grew from $ in to $157.78M in 2015 Q4. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Skyepharma is $81.49M. Shareholders equity comes under liabilities as it is money the company owes the holders of SKYEY stock.